Oct 08, 2025 11:00
AQST - Aquestive Therapeutics, Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
6.89 0.59 (8.56%) | --- | 0.06 (0.81%) | 0.14 (1.91%) | 0.11 (1.6%) | 0.34 (4.79%) | 0.0 (0.0%) | 0.0 (0.0%) |
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -0.14
- Diluted EPS:
- -0.14
- Basic P/E:
- -53.4279
- Diluted P/E:
- -53.4279
- RSI(14) 1m:
- 100.0
- VWAP:
- 7.48
- RVol:
- 1.1835
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Sep 04, 2025 11:00
Aug 14, 2025 10:00
Jul 22, 2025 11:00
Apr 09, 2025 11:00
Feb 12, 2025 12:00
Jun 27, 2024 12:00
Jun 03, 2024 12:00
May 24, 2024 12:59
May 09, 2024 12:00